Lactic-Acid-Bacteria-Containing Composition, Oral Pharmaceutical Composition for Treating HPV Infection and/or HPV-Associated Tumors, and Mucosal Immunity-Inducing Agent

USPTO Patent Application US 2018/0008663 A1
Application Date: Jan. 11st, 2018

ABSTRACT

A lactic acid bacterium-containing composition including a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof, wherein the HPV E7 protein-derived polypeptide is included...
Application Number:
15/547,273
International Classification:
A61K 38/02 (20060101); C12R 1/245 (20060101); C07K 14/025 (20060101); C12N 7/00 (20060101)
No Pictures Available

CLAIMS

What is claimed is:

1. A lactic acid bacterium-containing composition comprising a lactic acid bacterium having a human papillomavirus (HPV) E7 protein-derived polypeptide on a surface thereof,wherein the HPV E7 protein-derived polypeptide is included in an amount of 0.03 μg to 1.0 μg per 1×10′ lactic acid bacteria.

DESCRIPTION

TECHNICAL FIELD

The present invention relates to a lactic acid bacterium-containing composition in which a lactic acid bacterium has a human papilloma virus (HPV) E7 protein-derived polypeptide on a surface thereof a therapeutic oral pharmaceutical composition for at least one of an HPV infectious disease and an HPV-associated tumor which includes the...
Back to Top